The genomics market is rapidly growing and expected to reach USD 19.99 Billion by 2020, growing at a CAGR of 9.9% during the forecast period of 2015 to 2020. The growth of the overall market has resulted in the increasing number of start-up companies
In the last few decades, scientific research has enormously changed from performing experiments in a single lab to a dynamic collaborative environment with multiple research labs.
Modern healthcare is moving towards precision medicine rather than traditional one-size-fits-all approach. Recent advancements in technology are making this trend much faster than it was happening.
Airlite is a start-up which has developed unique products to tackle the indoor air pollution as well as in the small public areas. They have basically designed a paint which is VOC (Volatile organic compounds) free, made from natural materials and which reduces the air pollution by neutralizing pollutants like nitrogen oxide and nitrogen dioxide.
As per the OECD survey, US produces at least twice as many Ph.D. graduates compared Germany. According to the data around 67,449 graduated with a Ph.D. in 2014 from the US compared to 28,147 from Germany followed by UK, India, and Japan.
Our planet is covered by almost 70% of the water, and it is easy to consider that it will always be abundant. Nonetheless, freshwater—the substance we drink, bath in, irrigate our farms with—is incredibly rare. Only 3% of the world’s water is fresh water, and two-thirds of that is tucked away in frozen glaciers or otherwise inaccessible for our usage.
Diploid is a Leuven-based genomics start-up that aims to revolutionize healthcare by bringing genome diagnostics into daily clinical practice. Peter Schols, CEO of Diploid, founded the company in 2014 out of his passion for both software development and genetics.
Dr. Rita Chen is an Associate Research Fellow at the Institute of Biological Chemistry (IBC) and is also a TIGP-CBMB faculty member. Dr. Chen was awarded her Ph.D. degree from the Department of Biochemistry at the prestigious University of Cambridge in 1998.
Financial technology, or most commonly known as FinTech, is a business made up of companies that adopt latest technology and innovation with existing resources in order to contest in the marketplace of traditional financial establishments and mediators in the delivery of financial services.
Kevin Tsai recently graduated from the Ph.D. program in Bioinformatics at Academia Sinica, Taiwan. Prior to graduating, he did contract work with McKinsey & Co. and held positions at Gilead Sciences and Celera.